Back
ARK Innovation ETF Vs. Immunovant, Inc. Industry Stock Comparison
Buy
73
ARKK
ARK Innovation ETF
Last Price:
$80.26
Seasonality Move:
-2.96%
Sell
45
IMVT
Immunovant, Inc.
Last Price:
$26.66
Seasonality Move:
-32.5%
Buy
73
ARK Innovation ETF (ARKK)
is a Buy
Is ARK Innovation ETF a Buy, Sell or Hold?
-
The current ARK Innovation ETF [ARKK] share price is $80.30. The Score for ARKK is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
ARKK is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Immunovant, Inc. (IMVT)
is a Sell
Is Immunovant, Inc. a Buy, Sell or Hold?
-
The current Immunovant, Inc. [IMVT] share price is $26.68. The Score for IMVT is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
IMVT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARKK Stock Price Chart
What is ARK Innovation ETF's stock price today?
-
The ARK Innovation ETF share price today is $80.30The current trend is relatively stagnant and ARKK is experiencing slight buying pressure.
IMVT Stock Price Chart
What is Immunovant, Inc.'s stock price today?
-
The Immunovant, Inc. share price today is $26.68Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMVT is experiencing slight selling pressure.
ARKK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.33 | Sell |
| Relative Strength Index (14 RSI): | 50.02 | Buy |
| Chaikin Money Flow: | 3135634 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (75.64 - 81.66) | Buy |
| Bollinger Bands (100): | (75.23 - 86.19) | Sell |
IMVT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.16 | Buy |
| Relative Strength Index (14 RSI): | 65.7 | Buy |
| Chaikin Money Flow: | -1212454 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.59 - 25.55) | Buy |
| Bollinger Bands (100): | (15.22 - 23.06) | Buy |
ARKK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 80.21 | Buy |
| 20-day SMA: | 79.64 | Buy |
| 50-day SMA: | 82.32 | Sell |
| 200-day SMA: | 69.4 | Buy |
| 8-day EMA: | 79.84 | Buy |
| 20-day EMA: | 80.05 | Buy |
| 50-day EMA: | 80.72 | Sell |
| 200-day EMA: | 72.61 | Buy |
IMVT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.91 | Buy |
| 20-day SMA: | 24.21 | Buy |
| 50-day SMA: | 22.54 | Buy |
| 200-day SMA: | 17.71 | Buy |
| 8-day EMA: | 25.84 | Buy |
| 20-day EMA: | 24.64 | Buy |
| 50-day EMA: | 22.62 | Buy |
| 200-day EMA: | 20.1 | Buy |
ARK Innovation ETF Earnings Growth & ARKK Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Immunovant, Inc. Earnings Growth & IMVT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.13 per share, and a decrease next year of $0.05 per share.
ARK Innovation ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Immunovant, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||